Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1917 2
1918 1
1919 2
1923 1
1934 2
1935 1
1936 1
1937 2
1939 1
1940 2
1941 1
1943 1
1944 1
1947 1
1949 2
1950 3
1951 3
1953 1
1954 1
1955 1
1956 1
1959 2
1961 2
1962 5
1963 2
1964 2
1965 2
1966 3
1967 5
1968 1
1969 2
1970 2
1971 4
1972 9
1973 8
1974 5
1975 7
1976 9
1977 12
1978 4
1979 9
1980 15
1981 23
1982 21
1983 24
1984 17
1985 21
1986 25
1987 20
1988 27
1989 21
1990 15
1991 23
1992 28
1993 17
1994 20
1995 17
1996 20
1997 12
1998 17
1999 20
2000 13
2001 21
2002 25
2003 21
2004 25
2005 27
2006 29
2007 42
2008 52
2009 50
2010 44
2011 61
2012 47
2013 49
2014 86
2015 75
2016 59
2017 62
2018 78
2019 79
2020 181
2021 97
2022 103
2023 12
Text availability
Article attribute
Article type
Publication date

Search Results

1,732 results
Results by year
Filters applied: . Clear all
Page 1
Reply.
Daich Varela M, Brooks BP. Daich Varela M, et al. Among authors: brooks bp. Ophthalmology. 2021 Nov;128(11):e214-e215. doi: 10.1016/j.ophtha.2021.07.022. Epub 2021 Sep 1. Ophthalmology. 2021. PMID: 34481669 No abstract available.
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.
Shefner JM, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, Cockroft BM, Meng L, Wei J, Wolff AA, Malik FI, Bodkin C, Brooks BR, Caress J, Dionne A, Fee D, Goutman SA, Goyal NA, Hardiman O, Hayat G, Heiman-Patterson T, Heitzman D, Henderson RD, Johnston W, Karam C, Kiernan MC, Kolb SJ, Korngut L, Ladha S, Matte G, Mora JS, Needham M, Oskarsson B, Pattee GL, Pioro EP, Pulley M, Quan D, Rezania K, Schellenberg KL, Schultz D, Shoesmith C, Simmons Z, Statland J, Sultan S, Swenson A, Berg LHVD, Vu T, Vucic S, Weiss M, Whyte-Rayson A, Wymer J, Zinman L, Rudnicki SA. Shefner JM, et al. Among authors: brooks br. Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):287-299. doi: 10.1080/21678421.2020.1822410. Epub 2020 Sep 24. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32969758 Free PMC article. Clinical Trial.
Reply.
Turriff AE, Cukras CA, Brooks BP, Huryn LA. Turriff AE, et al. Among authors: brooks bp. J AAPOS. 2020 Feb;24(1):58-59. doi: 10.1016/j.jaapos.2019.10.009. Epub 2020 Jan 11. J AAPOS. 2020. PMID: 31935451 Free PMC article. No abstract available.
Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome.
Kozycki CT, Kodati S, Huryn L, Wang H, Warner BM, Jani P, Hammoud D, Abu-Asab MS, Jittayasothorn Y, Mattapallil MJ, Tsai WL, Ullah E, Zhou P, Tian X, Soldatos A, Moutsopoulos N, Kao-Hsieh M, Heller T, Cowen EW, Lee CR, Toro C, Kalsi S, Khavandgar Z, Baer A, Beach M, Long Priel D, Nehrebecky M, Rosenzweig S, Romeo T, Deuitch N, Brenchley L, Pelayo E, Zein W, Sen N, Yang AH, Farley G, Sweetser DA, Briere L, Yang J, de Oliveira Poswar F, Schwartz IVD, Silva Alves T, Dusser P, Koné-Paut I, Touitou I, Titah SM, van Hagen PM, van Wijck RTA, van der Spek PJ, Yano H, Benneche A, Apalset EM, Jansson RW, Caspi RR, Kuhns DB, Gadina M, Takada H, Ida H, Nishikomori R, Verrecchia E, Sangiorgi E, Manna R, Brooks BP, Sobrin L, Hufnagel RB, Beck D, Shao F, Ombrello AK, Aksentijevich I, Kastner DL; Undiagnosed Diseases Network. Kozycki CT, et al. Among authors: brooks bp. Ann Rheum Dis. 2022 Oct;81(10):1453-1464. doi: 10.1136/annrheumdis-2022-222629. Epub 2022 Jul 22. Ann Rheum Dis. 2022. PMID: 35868845 Free PMC article.
Antibody Printing Technologies.
Romanov V, Brooks BD. Romanov V, et al. Among authors: brooks bd. Methods Mol Biol. 2021;2237:151-177. doi: 10.1007/978-1-0716-1064-0_13. Methods Mol Biol. 2021. PMID: 33237416 Review.
Moving beyond Titers.
Brooks BD, Beland A, Aguero G, Taylor N, Towne FD. Brooks BD, et al. Vaccines (Basel). 2022 Apr 26;10(5):683. doi: 10.3390/vaccines10050683. Vaccines (Basel). 2022. PMID: 35632439 Free PMC article. Review.
Genotypic and Phenotypic Spectrum of Foveal Hypoplasia: A Multicenter Study.
Kuht HJ, Maconachie GDE, Han J, Kessel L, van Genderen MM, McLean RJ, Hisaund M, Tu Z, Hertle RW, Gronskov K, Bai D, Wei A, Li W, Jiao Y, Smirnov V, Choi JH, Tobin MD, Sheth V, Purohit R, Dawar B, Girach A, Strul S, May L, Chen FK, Heath Jeffery RC, Aamir A, Sano R, Jin J, Brooks BP, Kohl S, Arveiler B, Montoliu L, Engle EC, Proudlock FA, Nishad G, Pani P, Varma G, Gottlob I, Thomas MG. Kuht HJ, et al. Among authors: brooks bp. Ophthalmology. 2022 Jun;129(6):708-718. doi: 10.1016/j.ophtha.2022.02.010. Epub 2022 Feb 11. Ophthalmology. 2022. PMID: 35157951 Free article.
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.
Oskarsson B, Maragakis N, Bedlack RS, Goyal N, Meyer JA, Genge A, Bodkin C, Maiser S, Staff N, Zinman L, Olney N, Turnbull J, Brooks BR, Klonowski E, Makhay M, Yasui S, Matsuda K. Oskarsson B, et al. Among authors: brooks br. Neurodegener Dis Manag. 2021 Dec;11(6):431-443. doi: 10.2217/nmt-2021-0042. Epub 2021 Nov 24. Neurodegener Dis Manag. 2021. PMID: 34816762 Free article. Clinical Trial.
The Nocebo Effect and Pediatric Concussion.
Kirkwood MW, Howell DR, Brooks BL, Wilson JC, Meehan Iii WP. Kirkwood MW, et al. Among authors: brooks bl. J Sport Rehabil. 2021 May 28;30(6):837-843. doi: 10.1123/jsr.2020-0519. J Sport Rehabil. 2021. PMID: 34050035 Free article. Review.
1,732 results